Global Drug Eluting Stents (DES) Competitive Landscape Professional Research Report 2024

Global Drug Eluting Stents (DES) Competitive Landscape Professional Research Report 2024

Research Summary

Drug-eluting stents (DES) are medical devices used in the treatment of coronary artery disease. They are tiny, wire mesh tubes that are implanted in narrowed or blocked coronary arteries during a procedure called percutaneous coronary intervention (PCI) or angioplasty. What sets DES apart from traditional bare-metal stents is their coating with a medication, usually an anti-proliferative drug, that is slowly released over time. This drug helps inhibit the growth of cells that can lead to restenosis (re-narrowing) of the treated artery. By combining the mechanical support of the stent with the therapeutic effects of the drug, DES have significantly reduced the rate of restenosis compared to bare-metal stents. They play a crucial role in improving blood flow to the heart and reducing the need for repeat procedures in patients with coronary artery disease.

According to DIResearch's in-depth investigation and research, the global Drug Eluting Stents (DES) market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Drug Eluting Stents (DES) include Abbott Vascular, Advantec Vascular, B.Braun Melsengen, Biosensors, Biotronik, Blue Medical, DISA Vascular, Boston Scientific, Essen, Medtronic Vascular, MicroPort Medical, MIV Therapeutics, Promed Medical, Orbusneich, Relisys Medical, Reva Medical, Sahajanand, Sino Medical, Sorin etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Drug Eluting Stents (DES). Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Drug Eluting Stents (DES) market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Drug Eluting Stents (DES) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Drug Eluting Stents (DES) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Drug Eluting Stents (DES) Include:

Abbott Vascular

Advantec Vascular

B.Braun Melsengen

Biosensors

Biotronik

Blue Medical

DISA Vascular

Boston Scientific

Essen

Medtronic Vascular

MicroPort Medical

MIV Therapeutics

Promed Medical

Orbusneich

Relisys Medical

Reva Medical

Sahajanand

Sino Medical

Sorin

Drug Eluting Stents (DES) Product Segment Include:

Cobalt-chromium Alloy Stents

Magnesium Alloy Stents

Tyrosine Polycarbonate Stents

Nitinol Stents

Platinum Chromium Alloy Stents

Stainless Steel Stents

Other Materials

Drug Eluting Stents (DES) Product Application Include:

Coronary Artery Disease (CAD)

Acute Coronary Syndrome (ACS)

Stable Angina

Chronic Total Occlusion

Left Main Coronary Artery Disease

Other

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Drug Eluting Stents (DES) Industry PESTEL Analysis

Chapter 3: Global Drug Eluting Stents (DES) Industry Porter’s Five Forces Analysis

Chapter 4: Global Drug Eluting Stents (DES) Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Drug Eluting Stents (DES) Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Drug Eluting Stents (DES) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Drug Eluting Stents (DES) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Drug Eluting Stents (DES) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Drug Eluting Stents (DES) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Drug Eluting Stents (DES) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Drug Eluting Stents (DES) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Drug Eluting Stents (DES) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources